NeoGenomics sales and marketing update

NeoGenomics launched NeoSITE Barrett's Esophagus FISH test in the U.S. for the surveillance and diagnosis of high-grade dysplasia and esophageal cancer. The four-probe fluorescent in situ hybridizati...